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The Papillon±LefeÁvre syndrome, inherited in an
autosomal recessive pattern, manifests with
palmoplantar keratoderma and early, destructive
periodontitis. Recently, mutations in the gene
encoding cathepsin C have been disclosed in a
limited number of families with Papillon±LefeÁvre
syndrome. We have examined two multiplex
families with Papillon±LefeÁvre syndrome, and
evaluated the gene encoding cathepsin C for
mutations. The mutation detection strategy con-
sisted of polymerase chain reaction ampli®cation
of all seven exons and ¯anking intronic sequences,
followed by direct nucleotide sequencing. This
strategy identi®ed two missense mutations, W39S
and G301S, affecting highly conserved amino acid
residues within the cathepsin C polypeptide. The
affected individuals were homozygotes whereas
heterozygous carriers of the mutations were clini-
cally unaffected, con®rming the recessive nature of
the mutations. Addition of these cathepsin C gene
mutations into the expanding Papillon±LefeÁvre
syndrome mutation database allows further devel-
opment of genotype/phenotype correlations
towards understanding this severe genodermatosis.
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T
he Papillon±LefeÁvre syndrome (PLS; OMIM no.
245000) is a relatively rare autosomal recessive
condition manifesting with palmoplantar keratoder-
ma, combined with a rapidly progressive periodontitis
(Papillon and LefeÁvre, 1924; for reviews see Haneke,
1979; Hart and Shapira, 1994; Siragusa et al, 2000). The estimated
prevalence is one to four per 106 (Verma et al, 1979). The initial
clinical signs of skin involvement are usually evident during the ®rst
4 y of life, and a histopathologic examination of the affected skin
shows hyperkeratosis with psoriasiform parakeratosis. The gingival
involvement may be noticeable as early as 3 or 4 y of age. Both the
deciduous teeth and permanent teeth are lost prematurely, and in
general the patients affected by PLS are edentulous by the age of
15 y. Calci®cation of the dura mater has been suggested to be the
third component of the syndrome (Gorlin et al, 1964).
A number of suggestions for pathoetiology in PLS have been
advanced over the years, including immune abnormalities and
susceptibility to bacterial infections (see Hart and Shapira, 1994);
however, the link between the cutaneous and gingival ®ndings has
not been clear. Originally, the PLS locus was placed on human
chromosome 11q14 by homozygosity linkage mapping (Fischer
et al, 1997; Laass et al, 1997; Hart et al, 1998, 2000c), and quite
recently a number of mutations in patients with PLS have been
reported in the gene encoding human cathepsin C (CTSC)
(Toomes et al, 1999; Hart et al, 1999, 2000a, b). This gene consists
of a total of seven exons and the corresponding mRNA, 1.8 kb,
encodes a polypeptide of 463 amino acids. The deduced
polypeptide consists of a 24 amino acid signal peptide, a 206
amino acid propeptide, and 233 amino acid mature enzyme (Rao
et al, 1997). Cathepsin C, also known as dipeptidyl-peptidase I (EC
3.4.14.1), is a lysosomal cysteine proteinase, and apparently plays an
important role in intracellular degradation of proteins and in
activation of many serine proteinases within immune/in¯ammatory
cells, including polymorphonuclear leukocytes, monocyte-macro-
phages, and mast cells.
In this study, we report CTSC mutations in two families with
PLS, and the ®rst polymorphisms in the gene.
MATERIALS AND METHODS
Clinical material and diagnostic features
Family 1 The proband (I-2, Family 1 in Fig 1) was a 49-y-old female of
Puerto Rican origin, with severe periodontitis and characteristic cutaneous
®ndings diagnostic of PLS. Speci®cally, she had a history of bilateral scaly
patches on the feet, palms, and elbows since childhood. She also had
premature loss of both deciduous and permanent teeth, which required
replacement with dentures at the age of 12 y. She denied recurrent skin or
systemic infections.
The proband had 10 siblings, three of which (I-3, I-4, and I-5, Family 1
in Fig 1) were similarly affected. For example, the younger brother (I-5)
was noted to have yellow, ®ssured hyperkeratotic palms and soles with
slight pseudoainhum. Scaly hyperkeratotic plaques were present in elbows
and knees.
Histopathology of the brother's (I-5) skin from right elbow and right
palm revealed con¯uent parakeratosis, tortuous capillaries in the dermal
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papillae, and a sparse in®ltrate of lymphocytes around venules of the
super®cial plexus, changes reported to be indistinguishable from psoriasis
(Angel et al, 2001).
The proband's parents were dead but they were not known to have skin
or dental ®ndings similar to their affected children, and there was known
parental consanguinity.
Family 2 The proband at the time of initial examination was a 4-y-old
female, the second child of consanguineous Japanese parents (II-2, Family 2
in Fig 1). She had an older, clinically unaffected brother (II-1), whereas a
younger brother, 1 y of age (II-3), was clearly affected. The parents were
clinically normal, and the inheritance was therefore consistent with an
autosomal recessive pattern. The affected children had erythematous
hyperkeratotic lesions, which were ®rst noted on their feet at 4 mo of age,
and the lesions subsequently developed on their hands, elbows, and knees
(Fig 2a±d). Histopathology of the skin from the proband's brother (II-3) at
the age of 5 y revealed acanthosis with hyperkeratosis and parakeratosis
(Fig 3). There was evidence of follicular hyperkeratosis. The proband also
had a history of a liver abscess at the age of 5 y.
At the current age of 24 and 21 y, the two individuals with skin lesions
(II-2 and II-3) have minimal dental complaints and do not display overt
tooth loss. Panoramic X-ray examination of the teeth of the affected male
(II-3), however, revealed extensive alveolar resorption (Fig 2e).
Examination of his older sister's (II-2) teeth revealed similar but less
pronounced changes (not shown).
Leukocyte function studies, including neutrophil killer activity and
neutrophil phagocytic activity, were essentially normal (87% and 92%±95%
of the controls) in both patients at 24 and 21 y of age. Among the nine
lymphocyte surface markers tested, the affected sister's (II-2) values were
well within the normal range, whereas some of the affected brother's (II-3)
values (and speci®cally those for CD56, CD11b, CD11c, CD 57, and CD
16) were at the lower end of the normal values or just below the lower
limit.
DNA extraction DNA was isolated from peripheral blood specimens
from the probands and other available members of the nuclear families, as
indicated in Fig 1, by phenol-chloroform extraction using standard
procedures (Sambrook et al, 1989). Control DNA was obtained from 50
unrelated individuals with no evidence of a skin disease. DNA was used as a
template for polymerase chain reaction (PCR) ampli®cation of exons for
mutation detection analysis.
PCR The PCR ampli®cation of CTSC exons and of ¯anking intronic
sequences was performed using primers as previously indicated (Toomes
et al, 1999), except for the following newly developed primer pairs for
exons 1 and the 5¢ half of exon 7: exon 1F, 5¢-TCTTCACC-
TCTTTTCTCAGC-3¢; exon 1R, 5¢-GGTCCCCGAATCCAGTC-
AAG-3¢; exon 7-1F, 5¢-TAAGCAGAGATACAGAGAAG-3¢; exon 7-
1R, 5¢-GTAGTGGAGGAAGTCATCATATAC-3¢.
The PCR reactions were performed in a total volume of 50 ml
containing 1 3 PCR buffer and 1.25 U of Amplitaq polymerase (Perkin-
Elmer Cetus, Foster City, CA), in the presence of 4% dimethyl sulfoxide,
12.8 pmol of each primer, and 200 ng of genomic DNA. The ampli®cation
conditions were as follows: 5 min at 94°C for one cycle, followed by 38
cycles of 45 s at 94°C, 45 s at the annealing temperature of the primers
(exon 1, 55°C; exon 7-1, 53°C), and 45 s at 72°C in a thermal cycler
(Hybaid, Teddington, U.K.). Five microliter aliquots of the PCR products
were analyzed by 2% agarose gel electrophoresis.
DNA sequencing and veri®cation of the mutations by restriction
endonuclease digestion PCR products were directly sequenced by
using an ABI Prism 377 automated sequencing system (Perkin-Elmer
Figure 1. Pedigrees of Family 1 and Family 2 with Papillon±LefeÁvre
syndrome. The solid symbols refer to affected individuals, whereas the
half-solid symbols refer to clinically unaffected individuals shown to be
heterozygous carriers of a mutation. The open symbols refer to clinically
unaffected individuals. DNA from individuals indicated by a number under
their symbol were studied for mutations in the CTSC gene. Note that the
parents of the affected individuals in the two families are related.
Figure 2. Clinical ®ndings in Family 2. The
palms and soles of individual II-3 at the age of 21
y (a, b) show severe erythema and hyperkeratosis.
There was evidence of development of pseudoain-
hums on the ®ngers (arrowhead in panel a). The
24-y-old sister had well-de®ned erythematous pla-
ques on her elbows and knees (c, d). Panozamic
X-ray of the teeth of individual II-3 at the age of
21 y (e) shows general alveolar and tooth resorp-
tion (arrows).
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Cetus). Veri®cation of the mutation was performed by digestion of PCR
products ampli®ed from DNA obtained from the probands and his/her
immediate family members by restriction endonucleases. The PCR
products were digested at 37°C for AciI or MnlI for 15 h. The fragments
were examined on 3% or 3.5% agarose gel.
RESULTS
In Family 1, screening of CTSC for pathogenetic mutations
revealed that the four affected individuals were homozygous for a
G®C substitution at the nucleotide position 116 (Fig 4). A
clinically unaffected child (II-1) of an affected individual (I-4) was a
heterozygous carrier of this mutation (Fig 4). This novel nucleotide
substitution resulted in a change from tryptophan (TGG) to serine
(TCG) at the amino acid position 39, and this mutation was
designated W39S (Table I). This novel amino acid substitution
mutation affects an evolutionarily conserved tryptophan residue.
The nucleotide substitution also creates a new restriction enzyme
site for MnlI, which was used for veri®cation of the mutation in this
family. MnlI digestion also revealed that an unaffected older brother
(I-1) is not a carrier of this mutation (Fig 4). Screening of 100
chromosomes in healthy, unrelated control subjects by MnlI
digestion demonstrated the absence of the W39S mutation,
suggesting that it was indeed pathogenetic.
Screening of Family 2 for CTSC mutations revealed that the
parents (I-1 and I-2) were heterozygous for a G®A substitution at
nucleotide position 901, whereas the two affected children (II-2
and II-3) were homozygous for this mutation. This nucleotide
substitution resulted in a change from glycine (GGC) to serine
(AGC) at the amino acid position 301, and this mutation was
designated G301S (Table I). This mutation has been previously
noted in another unrelated family with PLS, and its presence has
Figure 4. Identi®cation and veri®cation of the homozygous mis-
sense mutation in Family 1. Direct nucleotide sequencing of the PCR
product spanning exon 1 revealed a homozygous 116G®C in the affected
individuals (I-2, I-3, I-4, and I-5) (top panel), whereas an unaffected child
(II-1) of the patient I-4 was heterozygous for this nucleotide change (middle
panel), compared with the normal sequence also found in an unaffected
brother (I-1) (lower panel). The mutation was designated W39S. Veri®ca-
tion of the mutation by digestion with MnlI (bottom panel). The mutation
created a new restriction enzyme site for MnlI, which cuts the 338 bp PCR
product in the case of the normal allele to 161 bp, 114 bp, 37 bp, 19 bp,
and 7 bp bands, and in case of the mutant allele to 114 bp, 81 bp, 80 bp, 37
bp, 19 bp, and 7 bp bands (the smaller bands are not visible). MW,
molecular weight markers jX174/HaeIII; C, control.
Figure 3. Histopathologic ®ndings in a skin biopsy from the knee of
individual II-3 of Family 2 at the age of 5 y. Note acanthosis and
hyperkeratosis with follicular hyperkeratosis, parakeratosis, and perivascular
in¯ammatory cell in®ltrates (scale bar: 300 mm; hematoxylin and eosin stain).
Table I. Nucleotide variations in the CTSC gene
Location Nucleotide positiona Nucleotide change Amino acid substitution Restriction enzyme site Allele frequencies
Mutations
Exon 1 (Family 1) 116 G (Trp) ® C (Ser) W39S Mnll ±
Exon 7 (Family 2) 901 G (Gly) ® A (Ser) G301S Acll ±
Polymorphisms
Intron 1 172 + 106 G ® A ± HaeIII 0.714/0.286
Exon 7 1173 T (Thr) ® G (Thr) T391T Bsll 0.953/0.047
Exon 7 1357 A (Ile) ® G (Val) I453V Msll 0.953/0.047
aNucleotide numbers refer to the open reading frame, the translation-initiation codon (ATG) being +1/+3 in CTSC cDNA sequence (GenBank accession no.
NM001814).
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been excluded from a control population of 200 unrelated healthy
control individuals (Toomes et al, 1999). This nucleotide substitu-
tion also abolished a restriction enzyme site for AciI, which was
used for veri®cation of the mutation. AciI digestion con®rmed that
the parents were heterozygous carriers of the mutation whereas the
affected individuals were homozygotes. The AciI digestion also
revealed that an unaffected brother (II-1) is not a carrier of this
mutation.
During the search for pathogenetic mutations in these two
families, three additional sequence variants were discovered
(Table I). One of them was an intronic nucleotide substitution
whereas another was a neutral polymorphism in exon 7 (T391T).
The third one, 1357 A®G, substituted an isoleucine in position
543 by a valine (I453V). The allele frequencies of these apparent
polymorphisms are indicated in Table I.
DISCUSSION
In this study, we have identi®ed homozygous missense mutations
W39S and G301S in two families with PLS. Discovery of the novel
CTSC mutation W39S brings the total number of distinct
mutations found in different families with PLS to 15 (Fig 5). Nine
of them are missense mutations, whereas ®ve are nonsense
mutations or small deletion mutations resulting in premature
termination codon for translation. In addition, one family has a
splicing mutation (486-1G®A) at the intron 2/exon 3 border.
The missense mutations, including W39S, affect critical, highly
conserved amino acids (Hart et al, 2000a), and eight out of nine
missense mutations reside within the mature enzyme domain of the
polypeptides (Fig 5). Also, three of the amino acid substitutions
lead to incorporation of a cysteine in the polypeptide. It is
conceivable therefore that these missense mutations result in
conformational changes that abolish the catalytic activity of the
enzyme. In fact, the activity of this enzyme has been shown to be
essentially undetectable in peripheral blood leukocytes of affected
individuals in two families with PLS as a result of missense
mutations V249F and Y347C (Toomes et al, 1999).
The novel missense mutation identi®ed in this study, W39S, was
found in homozygous state in all four affected individuals in Family
1, whereas a heterozygous carrier had no evidence of PLS.
Furthermore, this mutation was not present in 100 alleles in
unrelated control individuals, thus indicating that it is not a
polymorphism. This tryptophan residue is precisely conserved in
cathepsin C during evolution in various species between humans
and Schistosoma japonicum (see Fig 6). Interestingly, however, the
W39S mutation resides at the amino-terminal end of the propeptide
(Fig 5), which is cleaved off during processing of the polypeptide to
mature enzyme (Muno et al, 1993). It is conceivable then that the
W39S mutation interferes either with the transport of the proform
polypeptide from endoplasmic reticulum to lysosomes or impedes
the subsequent proteolytic processing of the polypeptide to mature
enzyme.
It is of interest that Family 2 with the G301S mutation had
clinical features not entirely typical of PLS. Speci®cally, the two
affected individuals in this family had retained their teeth up to their
current age of 24 and 21 y whereas classic cases with PLS are
edentulous by the age of 15 y. Such late onset of periodontitis has
been noted before (Willett et al, 1985; Brown et al, 1993; Fardal
et al, 1998). It is also of interest that the speci®c cathepsin C
mutation, Y347C, is associated with severe periodontitis but the
individuals homozygous with this mutation have no evidence of
syndromic skin manifestations (Hart et al, 2000b). Finally, another
autosomal recessive condition with palmoplantar keratoderma and
Figure 5. Schematic illustration of the cathepsin C polypeptide, deduced from cDNA, with domain organization, and positions of all CTSC
mutations disclosed thus far in patients with PLS. The premature termination codon and the putative splice site mutation are shown above the
molecule, whereas missense mutations are shown below. The mutations disclosed in this study are shown in bold. The amino acid positions at the domain
borders are indicated above the polypeptide.
Figure 6. Conservation of peptide segments encoded by exon 7 of the CTSC gene. The partial human sequences are compared with those in other
vertebrates indicated, as well as in Schistosoma japonicum (SchJp) and mansoni (SchMa). The conserved amino acids are boxed, and the positions of missense
and nonsense mutations are indicated by arrows. The dashed lines indicated additional sequences not shown. A similar comparison of sequences encoded by
exons 1±6 is presented elsewhere (Hart et al, 2000a).
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early periodontal destruction, the Haim±Munk syndrome (OMIM
no. 245010), has been shown to be allelic with PLS (Hart et al,
2000a). A recurrent missense mutation, Q286R, in exon 6 of the
CTSC gene has been identi®ed in several nuclear families with the
Haim±Munk syndrome, all of the same ancestry (Hart et al, 2000a).
The same study reported a nonsense mutation, Q286X, in the same
codon of CTSC in a family with classic features of PLS (Hart et al,
2000a). Collectively, this phenotypic variability of the CTSC
mutations suggests either phenotype/genotype correlations or
phenotypic modulation by associated genetic and/or epigenetic
factors that are not yet evident from the relatively small cohort of
patients.
The pathomechanistic implications of absent or markedly
reduced cathepsin C activities in PLS are not entirely clear but it
has been suggested that lack of functional CTSC may be associated
with reduced host response against bacteria in dental plaque and
possibly other sites (Oguzkurt et al, 1996; Czauderna et al, 1999).
CTSC plays an essential role in activating serine proteinases
expressed in the granules of bone marrow derived cells both of
myeloid and lymphoid series (McGuire et al, 1993). These serine
proteinases are implicated in a variety of in¯ammatory and immune
processes, including phagocytic destruction of bacteria. In fact,
previous leukocyte function studies have suggested depressed
neutrophil phagocytic and lytic activity and depressed chemotactic
response (Bullon et al, 1993; Ghaffar et al, 1999; Liu et al, 2000).
Although these leukocyte functions were well within the normal
limits in the two patients in Family 2, a number of lymphocyte
surface markers were at the low end of normal values or slightly
below the normal limits, suggesting immunologic de®ciencies.
Mechanistically, de®cient activation of leukocyte serine proteinases
due to lack of CTSC activity could possibly explain the severe
periodontitis in PLS. The mechanisms leading to hyperkeratotic
skin lesions are unclear, however. One could speculate that CTSC
plays a role in epithelial differentiation leading to characteristic
cutaneous ®ndings in PLS.
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